177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer

NCT05603559 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: 1.1 GBq (30 mCi) of 177Lu-P17-087
DRUG: 1.1 GBq (30 mCi) of 177Lu-P17-088

Sponsor

Peking Union Medical College Hospital